ClearPoint Neuro Narrows FY2026 Sales Guidance from $48.000M-$52.000M to $48.000M-$50.000M vs $49.000M Est
Benzinga Newsdesk 2 days ago
NewsGuidance
ClearPoint Neuro (NASDAQ:CLPT) narrows FY2026 sales outlook from $48.000 million-$52.000 million to $48.000 million-$50.000 million vs $49.000 million estimate.
ClearPoint Neuro (NASDAQ:CLPT) narrows FY2026 sales outlook from $48.000 million-$52.000 million to $48.000 million-$50.000 million vs $49.000 million estimate.